Some users report decreased energy and motivation for exercise, especially in the first 4-8 weeks
Severe, persistent pain (especially in the back) may signal pancreatitis
Retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors, currently unlicensed by the MHRA or EMA and still being evaluated in Phase 2 and Phase 3 clinical trials
Laboratory research record on GLP-1S [PMID: 37203328] PubMed laboratory record discussing GLP-1S in a research context
If you want clarity on a specific lab value or testing scenario, bring the result, your dose timeline, and a brief symptom log to your clinician
Although gastric bypass often induces remission of type 2 diabetessometimes within days of surgery due to changes in gut hormone secretionnot all patients achieve or maintain diabetes remission